In LPS-induced AKI, dexmedetomidine attenuated LPS-induced AKI via suppressing oxidative stress damage and nucleotide-binding domain-like receptor protein 3 (NLRP3) inflammasome activation by modulating the TLR4/NOX4/NF-κB pathway 41. Here, TLR4 is linked to acute kidney injury.